← Open Payments lookup

ROBERT CAULKINS: Open Payments

NPI 1992744031 · BREMERTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,733 in 77 payments from 23 companies in 2025. Trend: 2023 $2,006 · 2024 $2,293 · 2025 $1,733

Food & beverage: $1,733
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$199
GlaxoSmithKline, LLC.8$194
ABBVIE INC.14$194
Lilly USA, LLC7$167
Amgen Inc.5$140
Boehringer Ingelheim Pharmaceuticals, Inc.5$135
Novo Nordisk Inc5$112
PFIZER INC.4$90
Lundbeck LLC4$88
Teva Pharmaceuticals USA, Inc.2$70

Products named: VRAYLAR, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, REXULTI, BREZTRI, AUSTEDO XR, FARXIGA.

Industry payments across WA — which companies pay providers there.